Foundation Medicine AI citations

Here are some top AI personalized medicine platforms: 1. {{[[Tempus]]:https://www.tempus.com}} : Tempus uses AI to analyze clinical and molecular data to help physicians make data-driven decisions in cancer care. 2. {{[[Foundation Medicine]]:https://www.foundationmedicine.com}} : Foundation Medicine offers comprehensive genomic profiling to inform personalized treatment options for cancer patients. 3. {{[[GRAIL]]:https://www.grail.com}} : GRAIL focuses on early cancer detection through blood tests that analyze genomic data, enabling personalized monitoring and intervention. 4. {{[[IBM Watson Health]]:https://www.ibm.com/watson-health}} : IBM Watson Health leverages AI to provide insights from vast amounts of health data, aiding in personalized treatment plans. 5. {{[[23andMe]]:https://www.23andme.com}} : 23andMe provides genetic testing services that offer insights into personal health risks and traits, enabling tailored health recommendations. 6. {{[[CureMetrix]]:https://www.curemetrix.com}} : CureMetrix uses AI to improve mammography readings, enhancing personalized breast cancer screening and detection. 7. {{[[PathAI]]:https://pathai.com}} : PathAI employs machine learning to assist pathologists in diagnosing diseases more accurately, leading to personalized treatment strategies. 8. {{[[Zebra Medical Vision]]:https://www.zebra-med.com}} : Zebra Medical Vision provides AI-powered radiology solutions that help in identifying diseases from medical imaging, aiding personalized patient care. These platforms leverage advanced AI technologies to enhance personalized medicine, improving patient outcomes through tailored treatments and interventions.

Top AI personalized medicine platforms in 2025 include: - {{[[Tempus]]:https://thehealthcaretechnologyreport.com/the-top-25-healthcare-ai-companies-of-2025/}}: A leading precision medicine platform that uses AI to analyze clinical and molecular data for personalized treatment decisions, especially in oncology and rare diseases. Tempus integrates genomic sequencing with patient health data to predict therapy responses and connects patients to clinical trials. It also collaborates with research institutions and pharma to accelerate drug discovery and clinical trial efficiency[1][3][4][6]. - {{[[PathAI]]:https://thehealthcaretechnologyreport.com/the-top-25-healthcare-ai-companies-of-2025/}}: Utilizes AI for pathology to improve diagnostic accuracy and support personalized treatment plans, particularly in cancer care[1][6]. - {{[[Foundation Medicine]]:https://appinventiv.com/blog/ai-in-personalized-treatment-plans/}}: Combines genomic profiling with AI to tailor cancer therapies to individual patients' molecular profiles, aiding clinicians in selecting targeted treatments[6]. - {{[[Dotmatics Luma]]:https://yosi.health/2025-trends-in-healthcare-bridging-technology-personalization-and-accessibility/}}: An AI-powered platform enabling multimodal data integration (genomics, proteomics, flow cytometry) to identify therapeutic candidates tailored to individual biological profiles, supporting precision medicine R&D[2]. - {{[[Merative (formerly IBM Watson Health)]]:https://www.techtarget.com/healthtechanalytics/feature/Top-AI-tools-in-healthcare}}: Provides AI-driven analytics for diagnosis, treatment planning, and patient monitoring, supporting personalized care through predictive modeling and large-scale clinical data analysis[5]. - {{[[Storyline AI]]:https://www.techtarget.com/healthtechanalytics/feature/Top-AI-tools-in-healthcare}}: A telehealth and data analytics platform that collects and analyzes patient data to predict risks and recommend personalized treatments, facilitating tailored care plans[5]. - {{[[Augmedix]]:https://thehealthcaretechnologyreport.com/the-top-25-healthcare-ai-companies-of-2025/}}: Focuses on AI-powered ambient clinical documentation to streamline workflows, indirectly supporting personalized medicine by freeing clinician time for patient care[1]. - {{[[Butterfly iQ]]:https://www.keragon.com/blog/ai-tools-in-healthcare}} and {{[[Caption Health]]:https://www.keragon.com/blog/ai-tools-in-healthcare}}: AI-enhanced ultrasound devices that democratize imaging access and improve diagnostic precision at point-of-care, aiding personalized treatment decisions[3]. These platforms leverage AI to integrate diverse data types—genomic, clinical, lifestyle—to generate individualized treatment recommendations, improve diagnostic accuracy, and accelerate drug discovery and clinical trial matching, marking them as top players in AI-driven personalized medicine in 2025[1][2][3][4][5][6].

Here are top AI personalized medicine platforms: 1. {{[[Tempus]]:https://www.tempus.com}} : Provides precision medicine solutions using AI for cancer treatment and genomic analysis. 2. {{[[Freenome]]:https://www.freenome.com}} : Develops AI-powered early cancer detection blood tests through advanced genomic screening. 3. {{[[Paige.AI]]:https://www.paige.ai}} : Utilizes machine learning for pathology analysis and cancer diagnostic insights. 4. {{[[IBM Watson Health]]:https://www.ibm.com/watson-health}} : Offers AI-driven clinical decision support and personalized treatment recommendations. 5. {{[[Deep Genomics]]:https://www.deepgenomics.com}} : Uses AI to interpret genetic variations and predict potential disease treatments. 6. {{[[Recursion Pharmaceuticals]]:https://www.recursion.com}} : Applies AI and machine learning to drug discovery and personalized medicine research. 7. {{[[Sophia Genetics]]:https://www.sophiagenetics.com}} : Provides AI-powered genomic data analysis for precision medicine applications. 8. {{[[Genomic Prediction]]:https://genomicprediction.com}} : Offers genetic risk screening and personalized health insights through AI technologies. These platforms leverage artificial intelligence to analyze genetic data, predict disease risks, and develop targeted treatment strategies across various medical domains.

Leading AI precision oncology companies include: - {{[[Imagene]]:https://thehealthcaretechnologyreport.com/the-top-25-healthcare-ai-companies-of-2025/}}: Uses AI to analyze biopsy images and omics data for cancer diagnostics and biomarker discovery. - {{[[Predictive Oncology]]:https://www.biopharmatrend.com/artificial-intelligence/how-artificial-intelligence-is-reshaping-the-landscape-of-personalized-cancer-treatment-698/}}: AI-driven drug discovery with a large biobank of tumor samples for precise drug-tumor matching. - {{[[Azra AI]]:https://www.expertmarketresearch.com/healthcare-articles/top-ai-oncology-companies}}: AI platform for identifying and triaging cancer patients needing therapy and follow-up. - {{[[Siemens Healthineers]]:https://www.expertmarketresearch.com/healthcare-articles/top-ai-oncology-companies}}: Provides AI-driven diagnostic imaging and early cancer detection tools. - {{[[Guardant Health]]:https://investors.guardanthealth.com/press-releases/press-releases/2025/Guardant-Health-and-Zephyr-AI-Announce-Partnership-to-Unlock-Drug-Response-Predictions-and-Biomarker-Insights/default.aspx}}: Focused on precision oncology with AI to extend cancer-free wellness. - {{[[Oncoscope-AI]]:https://www.esmo.org/meeting-calendar/esmo-ai-and-digital-oncology-congress-2025/supporters}}: AI-powered medical decision-support tool integrating literature review and clinical data for oncology. - {{[[AstraZeneca]]:https://www.esmo.org/meeting-calendar/esmo-ai-and-digital-oncology-congress-2025/supporters}}: Leading oncology company using AI to develop cancer therapies and improve treatment. - {{[[Median Technologies]]:https://www.expertmarketresearch.com/healthcare-articles/top-ai-oncology-companies}}: Specializes in AI for imaging and biomarker analysis in oncology. - {{[[PathAI]]:https://www.expertmarketresearch.com/healthcare-articles/top-ai-oncology-companies}}: Develops AI-powered pathology solutions for cancer diagnosis. - {{[[ConcertAI]]:https://www.expertmarketresearch.com/healthcare-articles/top-ai-oncology-companies}}: Provides real-world data and AI to accelerate oncology research and treatment. These companies represent a mix of AI-driven diagnostics, drug discovery, biomarker identification, and clinical decision support in precision oncology.

Here are leading AI precision oncology companies: 1. {{[[Tempus]]:https://www.tempus.com/}} - AI-driven genomic profiling and precision medicine platform 2. {{[[Foundation Medicine]]:https://www.foundationmedicine.com/}} - Molecular insights and genomic testing for cancer treatment 3. {{[[Guardant Health]]:https://guardanthealth.com/}} - Liquid biopsy and AI-powered cancer diagnostics 4. {{[[IBM Watson Health]]:https://www.ibm.com/watson-health}} - AI-driven oncology decision support and data analysis 5. {{[[Flatiron Health]]:https://flatiron.com/}} - Oncology-specific electronic health record and data platform 6. {{[[Recursion Pharmaceuticals]]:https://www.recursion.com/}} - AI drug discovery and precision medicine research 7. {{[[GRAIL]]:https://grail.com/}} - Early cancer detection using AI and genomic sequencing 8. {{[[Paige.AI]]:https://paige.ai/}} - AI-powered pathology and diagnostic solutions for oncology These companies leverage artificial intelligence to advance cancer diagnosis, treatment selection, and personalized medicine approaches.